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Abstract Parkinson’s disease involves intracellular deposits of
K-synuclein in the form of Lewy bodies and Lewy neurites. The
etiology of the disease is unknown, however, several epidemio-
logical studies have implicated environmental factors, especially
pesticides. Here we show that several pesticides, including
rotenone, dieldrin and paraquat, induce a conformational change
in K-synuclein and significantly accelerate the rate of formation
of K-synuclein fibrils in vitro. We propose that the relatively
hydrophobic pesticides preferentially bind to a partially folded
intermediate conformation of K-synuclein, accounting for the
observed conformational changes, and leading to association and
subsequent fibrillation. These observations suggest one possible
underlying molecular basis for Parkinson’s disease. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Parkinson’s disease is the second most common neurode-
generative disease a¡ecting as many as one million Americans,
mostly over the age of 60. Recent investigations have shown
that Parkinson’s disease is a protein deposition disease involv-
ing intracellular deposits of K-synuclein in the form of Lewy
bodies and Lewy neurites [1]. The etiology of Parkinson’s
disease is unknown, but recent work has shown that, except
in extremely rare cases, there appears to be no direct genetic
basis [2]. However, several epidemiological studies have impli-
cated environmental factors, especially pesticides [3^8].
K-Synuclein, a relatively abundant brain protein of 140 ami-
no acids and of unknown function, was ¢rst identi¢ed in
association with synaptic vesicles [9]. K-Synuclein belongs to
the class of proteins known as natively unfolded; i.e. the pu-
ri¢ed protein at neutral pH is substantially disordered [10,11].
Fibrils of K-synuclein have been reported in Lewy bodies from
individuals with Lewy body diseases, as well as in vitro [12^
17]. We have recently established that the ¢brillation of
K-synuclein involves a critical partially folded intermediate
[11].
Here we show that certain pesticides can signi¢cantly stim-
ulate the formation of K-synuclein ¢brils. Since these agents
also induce a conformational change in K-synuclein, it is likely
that this partially folded conformation is a critical precursor
to association and ¢brillation. These observations suggest an
underlying molecular basis for Parkinson’s disease and related
Lewy body diseases.
2. Materials and methods
2.1. K-Synuclein preparation
A new procedure for producing and purifying K-synuclein was de-
veloped, by fusing its gene to a chitin-binding domain (CBD)/intein
system (IMPACT: New England Biolabs) and expressing the fusion
protein in Escherichia coli. This system allowed simple puri¢cation of
K-synuclein by binding of the CBD fusion protein with a chitin col-
umn, followed by addition of a thiol agent (dithiothreitol or cysteine)
to induce the cleavage reaction of the intein and release the K-synu-
clein. The resultant protein, which was highly homogeneous by poly-
acrylamide gel electrophoresis, was indistinguishable from authentic
K-synuclein based on its electrophoretic mobility and molecular mass
determined by electrospray mass spectrometry.
2.2. Pesticides
Diethyldithiocarbamate (DDC), dieldrin, paraquat and rotenone
were obtained from Sigma and used without further puri¢cation.
The ¢nal concentrations in the incubation solutions were 100 WM.
2.3. Fibril formation
Solutions of 0.5 ml K-synuclein (0.5 mg/ml (35 WM)) at pH 7.5 in 10
mM phosphate bu¡er were stirred at 37‡C in glass vials with micro
stir-bars. Fibril formation was monitored with thio£avine T (TFT)
£uorescence [18]: aliquots of 10 Wl were removed from the incubated
sample and added to 1.0 ml of 25 WM TFT. The presence of ¢brils
was con¢rmed by electron microscopy (EM) (negative staining with
uranyl acetate) and atomic force microscopy.
2.4. Fourier transform infrared (FTIR) spectra
Attenuated total re£ectance (ATR) data were collected on a Nicolet
800SX FTIR spectrometer equipped with an MCT detector. The IRE
(72U10U6 mm, 45‡ germanium trapezoid) was held in a modi¢ed
SPECAC out-of-compartment ATR apparatus. [19] Typically 1024
interferograms were co-added at 4 cm31 resolution. Data analysis
was performed with GRAMS32 (Galactic Industries). Secondary
structure content was determined from curve ¢tting to spectra decon-
voluted using second derivatives and Fourier self-deconvolution to
identify component band positions. Hydrated thin ¢lm samples were
prepared by drying 50 Wl of 1 mg/ml K-synuclein solution on a ZnSe
crystal with dry N2. The infrared spectra were collected, followed by
Fourier transformation using the spectrum of the clean crystal as a
background. Water (liquid and vapor) components were subtracted
from the protein spectrum.
3. Results
Solutions of recombinant K-synuclein at pH 7.5, 10 mM
phosphate bu¡er, stirred at 37‡C, formed ¢brils over a period
of days to weeks, depending on the protein concentration and
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ionic strength. However, the major determinant of the rate of
¢brillation was the degree of agitation, the more vigorous the
agitation, the faster the rate of ¢bril formation. In fact, with
very vigorous agitation, the e¡ects of variables such as ionic
strength, protein concentration and various additives were
greatly attenuated. As observed for other aggregating systems,
the kinetics of K-synuclein aggregation exhibit an initial lag,
followed by an exponential growth period, followed by a lev-
eling o¡ as ¢bril formation comes to a halt (Fig. 1). Under the
standard assay conditions used (pH 7.5, 37‡C, 10 mM phos-
phate bu¡er), the lag was s 2 weeks for 35 WM K-synuclein.
Fibril formation was monitored with TFT £uorescence [18],
and the presence of ¢brils was con¢rmed by EM (negative
staining with uranyl acetate) and atomic force microscopy.
3.1. Pesticide-stimulated K-synuclein ¢bril formation
If, as suggested by epidemiological studies, pesticide expo-
sure increases the risk of Parkinson’s disease, there are several
possible mechanisms that can be envisaged. The simplest of
these is that the pesticide itself directly interacts with K-synu-
clein and leads to accelerated ¢brillation. Thus we examined
the e¡ect of a number of commonly used pesticides on the
kinetics of K-synuclein ¢brillation. As shown in Fig. 1, the
pesticides, representing di¡erent chemical classes, dramatically
accelerated the rate of formation of ¢brils when incubated
with K-synuclein at pH 7.5, 37‡C. DDC and dieldrin were
the most e¡ective, under the experimental conditions used,
both in terms of enhanced kinetics and amounts of ¢brils
formed. Particularly noteworthy is the observation that rote-
none had a substantial accelerating e¡ect on K-synuclein ¢-
brillation, since it has recently been reported that rotenone
can induce the major features of Parkinson’s disease in rats
[20]. The experiments in Fig. 1 used low concentrations of
K-synuclein and 100 WM pesticide. Accelerated ¢brillation
was also observed with higher concentrations of K-synuclein
(150 WM) and with 15 WM pesticide (data not shown).
Although the concentration of K-synuclein in dopaminergic
neurons is not accurately known, it is likely to be at least
200 WM.
3.2. Pesticide-induced conformational changes in K-synuclein
In order to investigate the underlying molecular mechanism
for the accelerated ¢bril formation we looked for conforma-
tional changes induced by the pesticides. As noted, K-synu-
clein is a natively unfolded protein, meaning that in the puri-
¢ed state at pH 7.5 it exhibits biophysical properties expected
for an unfolded protein, rather than a tightly packed, native
globular molecule [11]. The presence of the pesticides that
increased the rate of ¢brillation induced a time-dependent
increase in the amount of secondary structure in K-synuclein,
as monitored by circular dichroism (CD) (Fig. 2). Comparison
of the time-dependent changes in CD and ¢bril formation
revealed that the conformational changes are slow, but pre-
cede association of K-synuclein, as monitored by light scatter-
ing and ¢bril formation. At low ionic strength the spectrum
was indicative of a substantially unfolded protein. FTIR anal-
ysis con¢rmed that the conformational change involves an
increase in L-structure (Fig. 2).
3.3. K-Synuclein aggregation involves a branched pathway
leading to both amorphous and ¢brillar aggregates
An interesting feature of the data shown in Fig. 1 is that the
¢nal TFT signal is di¡erent for di¡erent pesticides. The most
likely explanation is that there are fewer ¢brils present in
those systems with smaller ¢nal TFT signals. This might arise
if there were competing pathways for K-synuclein aggregation.
Fig. 1. Kinetics of K-synuclein ¢bril formation in the presence of
pesticides. Solutions of K-synuclein (35 WM) were incubated with
stirring at 37‡C, in 10 mM phosphate bu¡er, pH 7.5, in the pres-
ence of the indicated pesticides (100 WM) as described in the text.
Fibril formation was monitored by the increase in TFT £uorescence.
Key: control, F ; DDC, b ; dieldrin, a ; paraquat, S ; rotenone, P.
The lag times (h) and rate constants for ¢bril growth (elongation)
(h31) were as follows: DDC (9.9, 0.023), dieldrin (42.5, 0.026), rote-
none (137.2, 0.035), and paraquat (241.2, 0.038).
Fig. 2. Pesticide-induced conformational changes in K-synuclein.
Top panel: far-UV CD spectra of 35 WM K-synuclein in 10 mM
phosphate bu¡er, pH 7.5; dotted line is the control (no added pesti-
cide), solid line is in the presence of 100 WM DDC. Bottom panel:
second derivative ATR FTIR spectra of the amide I region of
K-synuclein in the absence (dotted) and presence of 100 WM rote-
none after 1 h incubation at 37‡C, pH 7.5.
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This was con¢rmed by electron micrograph images of the
aggregated material, which showed both ¢brils and amor-
phous deposits, Fig. 3, and ¢ltration experiments, which
showed no soluble K-synuclein present at the end of the re-
action.
4. Discussion
Our results demonstrate two important points: certain pes-
ticides induce a conformational change in K-synuclein, and
these same compounds also accelerate the rate of K-synuclein
¢bril formation. We propose that the underlying basis of both
key observations is that certain pesticides directly interact
with K-synuclein to bring about a conformational change to
a partially folded state with a high propensity to aggregate.
We have recently shown that the natively unfolded state of
K-synuclein arises from the large net negative charge at neu-
tral pH and the low intrinsic hydrophobicity, and that factors
that decrease the net charge or increase the relative hydro-
phobicity lead to population of a partially folded intermedi-
ate, which correlates with ¢brillation [11,21]. We believe that
relatively non-polar pesticides may preferentially bind to the
partially folded intermediate conformation (I, in Scheme 1)
and hence shift the equilibrium from the natively unfolded
state (UN) to the intermediate [11].
The intermediate then associates, leading eventually to ¢-
brils. Precedence for such a ligand-binding-induced shift in
equilibrium from an unfolded state to favor a partially folded
state has previously been reported [21^23]. The driving force
appears to be the preferential a⁄nity of the intermediate for
the ligand due to the greater exposure of contiguous hydro-
phobic regions on the surface of the intermediate relative to
the natively unfolded state. In the intermediate, interactions of
hydrophobic side-chains result in large hydrophobic patches,
increasing the potential a⁄nity of the protein for non-polar
pesticides, as well as increasing self-association. This self-asso-
ciation leads to formation of the critical nucleus on the path-
way to ¢brils. The pesticides that stimulated K-synuclein ¢bril
formation have in common the properties that they are both
relatively hydrophobic and relatively water-soluble. Based on
our observation that 8-anilinonaphthalene-1-sulfonic acid also
stimulates the aggregation of K-synuclein (data not shown),
we predict that many compounds that are relatively hydro-
phobic and water-soluble may induce K-synuclein ¢bril for-
mation.
Interestingly, K-synuclein appears to aggregate not only as
ordered ¢brils, but also as amorphous deposits. We attribute
the decreased TFT signal in the presence of some of the pes-
ticides to competition between ¢brillation and amorphous ag-
gregation, as evidenced by the presence of amorphous depos-
its in EM images. This means that there is an underlying
branched pathway (Scheme 2) in which the partially folded
intermediate partitions between pathways to either amor-
phous or ¢brillar aggregates. Scheme 2 is undoubtedly an
oversimpli¢cation: it is possible that there are two forms of
the intermediate present, one leading to amorphous deposits,
the other to ¢brils. Individual pesticides interact selectively
with the intermediate species on the respective pathways, lead-
ing to relatively more or less ¢brils.
The results suggest that a variety of environmental factors
can accelerate K-synuclein aggregation by increasing the con-
centration of the critical partially folded intermediate confor-
mation that leads to aggregation. For pesticides the e¡ect is
due to their preferential binding to the partially folded inter-
mediate conformation. This is an alternative mechanism to
that proposed by Betarbet et al. [20], who suggest that a
rotenone-induced defect in mitochondrial complex I is respon-
sible for the observed nigrostriatal dopaminergic degeneration
in rotenone-treated rats. Our observations of a direct stimu-
lation by pesticides on K-synuclein ¢brillation are very rele-
vant to Parkinson’s disease because they suggest that in the
presence of pesticides, herbicides or other small soluble hydro-
phobic molecules (including some products of oxidative
stress), the concentrations of K-synuclein required to cause
rapid formation of ¢brils are signi¢cantly reduced. The pres-
ence of pesticides in the brain has been demonstrated [24,25].
It remains to be determined how quickly K-synuclein ¢brils
will form with the concentrations of K-synuclein and pesti-
cides found in neurons. The concentration of both K-synuclein
and pesticide in the dopaminergic neurons is unknown at
present.
Thus direct interactions between K-synuclein and environ-
mental agents could play a role in the pathogenesis of nigros-
triatal degeneration and thus in the etiology of sporadic Par-
kinson’s disease. The critical cytotoxic agent remainsScheme 1.
Fig. 3. Aggregation of K-synuclein leads to both ¢brils and amor-
phous (arrows) deposits. Negatively stained (uranyl acetate) electron
micrograph.
Scheme 2.
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unknown, and could be an intermediate on the aggregation
pathway, the amorphous or ¢bril deposits, or an indirect ef-
fect, such as disruption of proteasome function due to the
aggregated K-synuclein.
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